Serotonin-deficient brains more vulnerable to social stress

February 9, 2015, Duke University
Credit: Martha Sexton/public domain

Mice genetically deficient in serotonin—a crucial brain chemical implicated in clinical depression—are more vulnerable than their normal littermates to social stressors, according to a Duke study appearing this week in the Proceedings of the National Academy of Sciences.

Following exposure to stress, the -deficient mice also did not respond to a standard antidepressant, fluoxetine (Prozac), which works by boosting serotonin transmission between neighboring neurons.

The new results may help explain why some people with seem unresponsive to treatment with selective serotonin reuptake inhibitors (SSRIs), the most common antidepressant drugs on the market today. The findings also point to several possible therapeutic strategies to explore for treatment-resistant depression.

"Our results are very exciting because they establish in a genetically defined animal model of serotonin deficiency, that low serotonin could be a contributing factor to the development of depression in response to psychosocial stress—and can lead to the failure of SSRIs to alleviate symptoms of depression," said senior author Marc Caron, the James B. Duke professor of cell biology in the Duke University School of Medicine, and a member of the Duke Institute for Brain Sciences.

The exact causes of depression are unclear. Although scientists have traditionally thought that low brain serotonin could cause depression, the idea is difficult to test directly and increasingly controversial. At the same time, researchers have gained a greater appreciation for the many environmental factors—especially stress—that can bring on or worsen depression.

In the new study, researchers used a transgenic mouse strain called Tph2KI that has only 20-40% of normal levels of serotonin in its brain. These mice harbor an extremely rare mutation that was first identified in a small group of people with major depression.

Caron's group has been studying how the Tph2KI mice respond to different kinds of stress, showing previously that serotonin deficiency can affect susceptibility to some types of stress but not others, findings that may have implications for understanding how low levels of serotonin could contribute to mental illness.

In the new study, lead author Benjamin Sachs, a postdoctoral researcher in Caron's group, tested the responses of these mice to a type of psychosocial stress: social defeat stress.

The team stressed out mice by housing them each with an aggressive stranger mouse briefly every day for 7-10 days. Later, the scientists examined whether the test mice would avoid interacting with an unfamiliar mouse—a depression-like behavior.

A week of social stress was not sufficient for normal mice to show signs of depression, but the serotonin-deficient mice did. Longer periods of stress exposure led to depression-like behavior in both groups.

The researchers then found that a 3-week treatment with Prozac following the stress exposure alleviated depression-like symptoms in normal mice, but not mutant mice.

Prozac and other SSRIs work by blocking the ability of cells to recapture serotonin, so it makes sense that the drugs would be less effective in animals with abnormally low levels of serotonin to begin with, Caron said.

A few case studies have suggested that targeting a brain area called the lateral habenula could help alleviate treatment-resistant depression. This area is known as a 'punishment' region of the brain because its neurons are active in the absence of reward. And scientists think that an overactive lateral habenula might trigger depression.

In the new study, the Caron group targeted the lateral habenula with a designer drug and receptor (called DREADDs for 'designer receptors exclusively activated by designer drugs') that allows them to control the activity of particular neurons in a living animal. Inhibiting lateral habenula neurons reversed the social avoidance behavior in the serotonin-deficient mice, they found.

Although DREADDs aren't appropriate for use in humans, showing that the lateral habenula-targeted drugs can be used to alleviate depression-like behavior in animals is "an important first step," Sachs said.

"The next step is to figure out how we can turn off this brain region in a relatively non-invasive way that would have better therapeutic potential," Sachs added.

Another clue for potential new therapies came from biochemical comparisons of the brains of the mutant and normal mice. The researchers found that social stressors seemed to change where in the brain the signaling molecule β-catenin is being produced in normal mice, but not in the Tph2KI mice.

Taken with other evidence, these new findings suggest that serotonin deficiency may block a critical molecular pathway that includes β-catenin and that may be involved in resilience.

"If we can identify what's both upstream and downstream of β-catenin we might be able to come up with attractive drug targets to activate this pathway and promote resilience," Sachs said.

Explore further: Good things come to those who wait? More serotonin, more patience

More information: "Brain 5-HT deficiency increases stress vulnerability and impairs antidepressant responses following psychosocial stress," Benjamin D. Sachs, Jason R. Ni, Marc G. Caron. Proceedings of the National Academy of Sciences, Feb. 9, 2015. DOI: 10.1073/pnas.1416866112

Related Stories

Good things come to those who wait? More serotonin, more patience

January 15, 2015
In a study published today in the journal Current Biology, a team of scientists, led by Zachary Mainen at the Champalimaud Centre for the Unknown (CCU), found a causal link between the activation of serotonin neurons and ...

New study throws into question long-held belief about depression

August 27, 2014
New evidence puts into doubt the long-standing belief that a deficiency in serotonin—a chemical messenger in the brain—plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that ...

Scientists revisit biochemical basis for depression

February 12, 2013
Symptoms of depression and anxiety can be induced in mice by increasing levels of acetylcholine, suggesting that depression may have different biochemical roots than previously believed, Yale School of Medicine researchers ...

Early exposure to antidepressants affects adult anxiety and serotonin transmission

December 19, 2014
About 15 percent of women in the United States suffer from anxiety disorders and depression during their pregnancies, and many are prescribed antidepressants. However little is known about how early exposure to these medications ...

Why some antidepressants may initially worsen symptoms

December 17, 2014
New research helps explain a paradoxical effect of certain antidepressants—that they may actually worsen symptoms before helping patients feel better. The findings, highlighted in a paper publishing online December 17 in ...

A paradox revealed: Cues associated with infant abuse may help reduce stress in adult brain

January 14, 2015
Neurobiologists at NYU Langone Medical Center and elsewhere have found a surprising and paradoxical effect of abuse-related cues in rat pups: those cues also can lower depressive-like behavior when the rat pups are fully ...

Recommended for you

Forty percent of people have a fictional first memory, says study

July 17, 2018
Researchers have conducted one of the largest surveys of people's first memories, finding that nearly 40 per cent of people had a first memory which is fictional.

Protein found to be key component in irregularly excited brain cells

July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor ...

Insight without incision: Advances in noninvasive brain imaging offers improvements to epilepsy surgery

July 17, 2018
About a third of epilepsy sufferers require treatment through surgery. To check for severe epilepsy, clinicians use a surgical procedure called electrocorticography (ECoG). An ECoG maps a section of brain tissue to help clinicians ...

New drug target for remyelination in MS is identified

July 17, 2018
Remyelination, the spontaneous regeneration of the fatty insulator in the brain that keeps neurons communicating, has long been seen as crucial to the next big advance in treating multiple sclerosis (MS). However, a lack ...

Artificial neural networks now able to help reveal a brain's structure

July 17, 2018
The function of the brain is based on the connections between nerve cells. In order to map these connections and to create the connectome, the "wiring diagram" of a brain, neurobiologists capture images of the brain with ...

Convergence of synaptic signals is mediated by a protein critical for learning and memory

July 16, 2018
Inside the brain, is a complex symphony of perfectly coordinated signaling. Hundreds of different molecules amplify, modify and carry information from tiny synaptic compartments all the way through the entire length of a ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gettingwell
1 / 5 (1) Feb 27, 2015
Will the causes be found by studying the serotonin and β-catenin molecules?

Will the causes be found by drugs that turn off or turn on parts of the brain?

Where is the research on treating the enduring physiological responses to stress with goals for reversing them, instead of ignoring the causes and only treating the effects?

http://surfaceyou...ealself/

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.